How have MITPF shares performed in 2024?

Mithra Pharmaceuticals' stock was trading at $6.75 at the beginning of the year. Since then, MITPF stock has increased by 0.0% and is now trading at $6.75. View the best growth stocks for 2024 here .

How do I buy shares of Mithra Pharmaceuticals?

Shares of MITPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MITPF

Mithra Pharmaceuticals (MITPF) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free MITPF Stock Alerts

$6.75

0.00 (0.00%)

(As of 05/12/2023)

Compare

Today's Range: $6.75
▼
$6.75
50-Day Range: $6.75
▼
$6.75
52-Week Range: $6.75
▼
$7.75

Volume: N/A
Average Volume: 1,600 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Headlines Short Interest

Get Mithra Pharmaceuticals alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Mithra Pharmaceuticals Stock (OTCMKTS:MITPF)

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Belgium, Europe and internationally. Its development candidates include Estelle, a combined oral contraceptive that has completed phase III clinical trial; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment; and products for neuroprotection and wound healing. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a tablet composed of tibolone and a synthetic steroid used for hormone therapy in menopause; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. The company was founded in 1999 and is headquartered in Liège, Belgium.

MITPF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MITPF Stock News Headlines

April 17, 2024 | morningstar.com

Mithra Pharmaceuticals SA MITRAb

March 8, 2024 | finance.yahoo.com

Mithra reports full year 2023 financial results

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 5, 2024 | finanznachrichten.de

Mithra Pharmaceuticals: Mithra announces changes to its executive management

March 5, 2024 | finanznachrichten.de

Mithra Pharmaceuticals: Mithra initiates monetization process, receives bridge loan from existing lenders

March 5, 2024 | finance.yahoo.com

Mithra announces changes to its executive management

March 5, 2024 | finance.yahoo.com

Mithra initiates monetization process, receives bridge loan from existing lenders

March 5, 2024 | finance.yahoo.com

Mithra announces changes to its executive management

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 29, 2024 | finance.yahoo.com

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

February 6, 2024 | finanznachrichten.de

Mithra Pharmaceuticals: Mithra updates on cash position

February 6, 2024 | finance.yahoo.com

Mithra updates on cash position

January 19, 2024 | barrons.com

Mithra Pharmaceuticals S.A.

January 17, 2024 | morningstar.com

Mithra Pharmaceuticals SA MITRA

December 21, 2023 | finance.yahoo.com

Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel

December 20, 2023 | finanznachrichten.de

Mithra Pharmaceuticals: Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

December 20, 2023 | finance.yahoo.com

Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

December 18, 2023 | markets.businessinsider.com

Mithra Reports Positive Review From DSMB On European Phase 3 Program For DONESTA

December 18, 2023 | finance.yahoo.com

Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial

December 4, 2023 | markets.businessinsider.com

Mithra: Gedeon Richter To Have Commercial Rights For ESTELLE, DONESTA In China

December 4, 2023 | finance.yahoo.com

Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

November 30, 2023 | finance.yahoo.com

Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

November 28, 2023 | finance.yahoo.com

Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam

November 7, 2023 | finance.yahoo.com

Mithra’s NEXTSTELLIS® granted additional patent in the United States

November 6, 2023 | finance.yahoo.com

Mithra releases invitation to its extraordinary securities holders’ meeting

October 23, 2023 | finance.yahoo.com

Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement

October 17, 2023 | finance.yahoo.com

Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting

See More Headlines

Receive MITPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mithra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: OTCMKTS:MITPF
CUSIP: N/A
CIK: N/A
Web: www.mithra.com
Phone: 32 4 349 28 22
Fax: N/A
Employees: 270
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Christophe Marechal
Co-CEO & CFO
Mr. Xavier Paoli M.Sc.
COO & Co-CEO
Dr. Graham K. Dixon Ph.D. (Age 63)
Chief Scientific Officer
Mr. Alex Sokolowski
Head of Investor Relations
Fanny Rozenberg
Secretary of the Board & General Counsel
Fanny Storms
Compliance Officer
Mr. Frederique Depraetere
Communication Director
Ms. Catherine Lejeune
HR Director
Mr. Jean-Manuel Fontaine
Chief Commercial & External Affairs Officer
Prof. Jean-Michel Foidart M.D.
Ph.D., President of the Scientific Advisory Board & Executive Director

Key Competitors

View All Competitors

MITPF Stock Analysis - Frequently Asked Questions

How have MITPF shares performed in 2024?: Mithra Pharmaceuticals' stock was trading at $6.75 at the beginning of the year. Since then, MITPF stock has increased by 0.0% and is now trading at $6.75.
View the best growth stocks for 2024 here.
How do I buy shares of Mithra Pharmaceuticals?: Shares of MITPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MITPF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Mithra Pharmaceuticals (MITPF) Stock Price, News & Analysis

About Mithra Pharmaceuticals Stock (OTCMKTS:MITPF)

MITPF Stock Price History

MITPF Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MITPF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info